440 related articles for article (PubMed ID: 22956765)
1. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.
Timmerman I; Hoogenboezem M; Bennett AM; Geerts D; Hordijk PL; van Buul JD
Mol Biol Cell; 2012 Nov; 23(21):4212-25. PubMed ID: 22956765
[TBL] [Abstract][Full Text] [Related]
2. SHP2 association with VE-cadherin complexes in human endothelial cells is regulated by thrombin.
Ukropec JA; Hollinger MK; Salva SM; Woolkalis MJ
J Biol Chem; 2000 Feb; 275(8):5983-6. PubMed ID: 10681592
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
Hatanaka K; Lanahan AA; Murakami M; Simons M
PLoS One; 2012; 7(5):e37600. PubMed ID: 22629427
[TBL] [Abstract][Full Text] [Related]
4. Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium.
Grinnell KL; Casserly B; Harrington EO
Am J Physiol Lung Cell Mol Physiol; 2010 Mar; 298(3):L361-70. PubMed ID: 20023173
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation.
Fu P; Ramchandran R; Shaaya M; Huang L; Ebenezer DL; Jiang Y; Komarova Y; Vogel SM; Malik AB; Minshall RD; Du G; Tonks NK; Natarajan V
J Biol Chem; 2020 May; 295(22):7669-7685. PubMed ID: 32327488
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine.
Starosta V; Wu T; Zimman A; Pham D; Tian X; Oskolkova O; Bochkov V; Berliner JA; Birukova AA; Birukov KG
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):331-41. PubMed ID: 21997484
[TBL] [Abstract][Full Text] [Related]
7. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB
Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526
[TBL] [Abstract][Full Text] [Related]
8. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.
Zhang J; Huang J; Qi T; Huang Y; Lu Y; Zhan T; Gong H; Zhu Z; Shi Y; Zhou J; Yu L; Zhang X; Cheng H; Ke Y
FASEB J; 2019 Jan; 33(1):1124-1137. PubMed ID: 30102570
[TBL] [Abstract][Full Text] [Related]
9. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function.
Chattopadhyay R; Raghavan S; Rao GN
Redox Biol; 2017 Aug; 12():438-455. PubMed ID: 28319894
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.
Hatanaka K; Simons M; Murakami M
Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H162-72. PubMed ID: 21037229
[TBL] [Abstract][Full Text] [Related]
11. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca
Soni D; Regmi SC; Wang DM; DebRoy A; Zhao YY; Vogel SM; Malik AB; Tiruppathi C
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L1003-L1017. PubMed ID: 28385807
[TBL] [Abstract][Full Text] [Related]
12. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
Adam AP; Sharenko AL; Pumiglia K; Vincent PA
J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
[TBL] [Abstract][Full Text] [Related]
13. ICAM-1-mediated, Src- and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration.
Allingham MJ; van Buul JD; Burridge K
J Immunol; 2007 Sep; 179(6):4053-64. PubMed ID: 17785844
[TBL] [Abstract][Full Text] [Related]
14. Distribution of adherens junction mediated by VE-cadherin complex in rat spleen sinus endothelial cells.
Uehara K
Cell Tissue Res; 2006 Mar; 323(3):417-24. PubMed ID: 16244888
[TBL] [Abstract][Full Text] [Related]
15. p120-Catenin prevents neutrophil transmigration independently of RhoA inhibition by impairing Src dependent VE-cadherin phosphorylation.
Alcaide P; Martinelli R; Newton G; Williams MR; Adam A; Vincent PA; Luscinskas FW
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C385-95. PubMed ID: 22648953
[TBL] [Abstract][Full Text] [Related]
16. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
Ha CH; Bennett AM; Jin ZG
J Biol Chem; 2008 Mar; 283(11):7261-70. PubMed ID: 18180305
[TBL] [Abstract][Full Text] [Related]
17. M3 muscarinic acetylcholine receptor dysfunction inhibits Rac1 activity and disrupts VE-cadherin/β-catenin and actin cytoskeleton interaction.
Jiao ZY; Wu J; Wen B; Zhao WZ; Du XL
Biochem Cell Biol; 2014 Apr; 92(2):137-44. PubMed ID: 24697698
[TBL] [Abstract][Full Text] [Related]
18. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation and the small GTPase rac cross-talk in regulation of endothelial barrier function.
Seebach J; Mädler HJ; Wojciak-Stothard B; Schnittler HJ
Thromb Haemost; 2005 Sep; 94(3):620-9. PubMed ID: 16268481
[TBL] [Abstract][Full Text] [Related]
20. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
